Your browser doesn't support javascript.
loading
Anti-HBV drug entecavir ameliorates DSS-induced colitis through PD-L1 induction.
Yamamoto, Yuichiro; Carreras, Joaquim; Shimizu, Takanobu; Kakizaki, Masatoshi; Kikuti, Yara Yukie; Roncador, Giovanna; Nakamura, Naoya; Kotani, Ai.
Afiliação
  • Yamamoto Y; Division of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara 259-1193, Japan; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara 259-1193, Japan.
  • Carreras J; Department of Pathology, Tokai University School of Medicine, Isehara 259-1193, Japan.
  • Shimizu T; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara 259-1193, Japan.
  • Kakizaki M; Division of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara 259-1193, Japan; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara 259-1193, Japan.
  • Kikuti YY; Department of Pathology, Tokai University School of Medicine, Isehara 259-1193, Japan.
  • Roncador G; Monoclonal Antibodies Unit, Spanish National Cancer Research Institute (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain.
  • Nakamura N; Department of Pathology, Tokai University School of Medicine, Isehara 259-1193, Japan.
  • Kotani A; Division of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara 259-1193, Japan; Department of Innovative Medical Science, Tokai University School of Medicine, Isehara 259-1193, Japan. Electronic address: aikotani@k-lab.jp.
Pharmacol Res ; 179: 105918, 2022 05.
Article em En | MEDLINE | ID: mdl-35031477

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite / Antígeno B7-H1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite / Antígeno B7-H1 Idioma: En Ano de publicação: 2022 Tipo de documento: Article